Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 34 Uterine Cervical Neoplasms 24 Fallopian Tube Neoplasms 18 Endometrial Neoplasms 16 Neoplasm Metastasis 10 Lung Neoplasms 9 Pancreatic Neoplasms 8 Stomach Neoplasms 7 Colorectal Neoplasms 7 Carcinoma, Transitional Cell 7 Breast Neoplasms 7 Melanoma 6 Carcinoma, Renal Cell 6 Prostatic Neoplasms 5 Esophageal Neoplasms 5 Carcinosarcoma 5 Carcinoma, Hepatocellular 5 Vaginal Neoplasms 4 Triple Negative Breast Neoplasms 4 Thyroid Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Testicular Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Multiple Myeloma 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Vulvar Neoplasms 2

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 2 fluoroazomycin arabinoside 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Injections 1 Drug Therapy 1 Diagnostic Imaging 1 Blood Specimen Collection 1 AQ4N 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Magnetic Resonance Spectroscopy × Gynecologic × Clear all

NCT02233387 2019-03-08

HX4-cervix

Maastricht Radiation Oncology

Phase 2 Terminated

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡